AI assistant
Sending…
Moderna, Inc. — Director's Dealing 2020
Jun 4, 2020
30610_dirs_2020-06-04_14a68c4a-975e-410f-a9d1-334cf164be42.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-05-12
Reporting Person: NABEL ELIZABETH G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-12 | Common Stock | S | 30000 | $66.00 | Disposed | 14344 | Direct |
Footnotes
F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2020.
More from Moderna, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 11
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 23
Annual Report
2026
Feb 20
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 13